FDA.reportPublic FDA data

Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension

RxCUI
1251365
RxNorm name
Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension
Display name
Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension
Full name
Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GAVISCONALUMINUM HYDROXIDE AND MAGNESIUM CARBONATEHaleon US Holdings LLC2d74e5bc-1f10-4fb6-9258-cd906e3600132026-02-13WarningsExact identifier
rxcui: 1251365

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
2d74e5bc-1f10-4fb6-9258-cd906e360013Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral SuspensionSY23Drug Facts20260213
2d74e5bc-1f10-4fb6-9258-cd906e360013Gaviscon Regular Strength 95 MG / 358 MG in 15 mL Oral SuspensionPSN23Drug Facts20260213
2d74e5bc-1f10-4fb6-9258-cd906e360013aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon]SBD23Drug Facts20260213
2d74e5bc-1f10-4fb6-9258-cd906e360013Gaviscon (aluminum hydroxide 95 MG / magnesium carbonate 358 MG) per 15 ML Oral SuspensionSY23Drug Facts20260213